BRCA1 and posterior cortical atrophy: Examples comprise the Manchester scoring system, identifying patients with a > 10% probability of PGVs in BRCA1/2 [10], the Amsterdam II criteria and the PREMM5 score, predicting the probability of underlying LS-associated gene alterations [11, 12], or the Johns Hopkins criteria to identify hereditary PCa families to offer early screening [13].